{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:49:58Z","timestamp":1760204998727},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-018-2621-x","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T12:50:57Z","timestamp":1544791857000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Has doxycycline, in combination with anti-malarial drugs, a role to play in intermittent preventive treatment of Plasmodium falciparum malaria infection in pregnant women in Africa?"],"prefix":"10.1186","volume":"17","author":[{"given":"Tiphaine","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Boxberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marylin","family":"Madamet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"2621_CR1","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.","edition":"3"},{"key":"2621_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet. 2014;383:723\u201335.","journal-title":"Lancet."},{"key":"2621_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12936-016-1627-5","volume":"15","author":"D Almond","year":"2016","unstructured":"Almond D, Madanitsa M, Mwapasa V, Kalilani-Phiri L, Webster J, Ter Kuile F, et al. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi. Malar J. 2016;15:574.","journal-title":"Malar J."},{"key":"2621_CR4","volume-title":"Recommendations on antenatal care for a positive pregnancy experience","author":"WHO","year":"2016","unstructured":"WHO. Recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization; 2016."},{"key":"2621_CR5","volume-title":"World malaria report 2017","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization; 2017."},{"key":"2621_CR6","doi-asserted-by":"publisher","first-page":"73073","DOI":"10.1371\/journal.pone.0073073","volume":"8","author":"E Arinaitwe","year":"2013","unstructured":"Arinaitwe E, Ades V, Walakira A, Ninsiima B, Mugagga O, Patil TS, et al. Intermittent preventive therapy with sulfadoxine\u2013pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda. PLoS One. 2013;8:73073.","journal-title":"PLoS One."},{"key":"2621_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207\u201311.","journal-title":"Nature"},{"key":"2621_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/infdis\/jit276","volume":"208","author":"J Gutman","year":"2013","unstructured":"Gutman J, Mwandama D, Wiegand RE, Mathanga DP, Skarbinski J. Effectiveness of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. J Infect Dis. 2013;208:907\u201316.","journal-title":"J Infect Dis."},{"key":"2621_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12936-015-0576-8","volume":"14","author":"KE Mace","year":"2015","unstructured":"Mace KE, Chalwe V, Katalenich BL, Nambozi M, Mubikayi L, Mulele CK, et al. Evaluation of sulphadoxine\u2013pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Malar J. 2015;14:69.","journal-title":"Malar J."},{"key":"2621_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kaventao K, et al. Impact of sulfadoxine\u2013pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62:323\u201333.","journal-title":"Clin Infect Dis"},{"key":"2621_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/cix026","volume":"64","author":"RM Chico","year":"2017","unstructured":"Chico RM, Chaponda EB, Ariti C, Chandramohan D. Sulfadoxine\u2013pyrimethamine exhibits dose\u2013response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infections. Clin Infect Dis. 2017;64:1043\u201351.","journal-title":"Clin Infect Dis"},{"key":"2621_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12936-017-1831-y","volume":"16","author":"E Ruizendaal","year":"2017","unstructured":"Ruizendaal E, Tahita MC, Geskus RB, Versteeq I, Scott S, d\u2019Alessandro U, et al. Increase in the prevalence of mutations associated with sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso. Malar J. 2017;16:179.","journal-title":"Malar J."},{"key":"2621_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12936-017-1695-1","volume":"16","author":"M Cisse","year":"2017","unstructured":"Cisse M, Awandare GA, Soulama A, Tinto H, Hayette MP, Guiguemd\u00e9 RT. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine\u2013pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. Malar J. 2017;16:38.","journal-title":"Malar J."},{"key":"2621_CR14","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(15)00310-4","volume":"386","author":"M Desai","year":"2015","unstructured":"Desai M, Gutman J, L\u2019Lanziva A, Otieno K, Juma E, Kariuki S, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin\u2013piperaquine versus intermittent preventive treatment with sulfadoxine\u2013pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomized controlled superiority trial. Lancet. 2015;386:2507\u201319.","journal-title":"Lancet"},{"key":"2621_CR15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1056\/NEJMoa1509150","volume":"374","author":"A Kakuru","year":"2016","unstructured":"Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, et al. Dihydroartemisinin\u2013piperaquine for the prevention of malaria pregnancy. N Engl J Med. 2016;374:928\u201339.","journal-title":"N Engl J Med"},{"key":"2621_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016;16:357\u201365.","journal-title":"Lancet Infect Dis."},{"key":"2621_CR17","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1128\/AAC.00835-15","volume":"59","author":"R Leang","year":"2015","unstructured":"Leang R, Taylor WRJ, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin\u2013piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother. 2015;59:4719\u201326.","journal-title":"Antimicrob Agents Chemother"},{"key":"2621_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","volume":"15","author":"MD Spring","year":"2015","unstructured":"Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin\u2013piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683\u201391.","journal-title":"Lancet Infect Dis."},{"key":"2621_CR19","doi-asserted-by":"publisher","first-page":"e01068","DOI":"10.1128\/AAC.01068-18","volume":"62","author":"S Dini","year":"2018","unstructured":"Dini S, Zaloumis S, Cao P, Price RN, Fowkes FJI, van der Pluijm RW, et al. Investigating the efficacy of triple artemisinin-based combination therapies for treating Plasmodium falciparum malaria patients using mathematical modeling. Antimicrob Agents Chemother. 2018;62:e01068\u2013718.","journal-title":"Antimicrob Agents Chemother"},{"key":"2621_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","volume":"14","author":"T Gaillard","year":"2015","unstructured":"Gaillard T, Madamet M, Pradines B. Tetracyclines in malaria. Malar J. 2015;14:445.","journal-title":"Malar J."},{"key":"2621_CR21","volume-title":"Health information for international travel. Yellow book 2018","author":"CDC","year":"2018","unstructured":"CDC. Health information for international travel. Yellow book 2018. Atlanta: Centers for Diseases Control and Prevention; 2018."},{"key":"2621_CR22","volume-title":"Recommandations sanitaires pour les voyageurs 2018. Bulletin Epid\u00e9miologique Hebdomadaire","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2018","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Recommandations sanitaires pour les voyageurs 2018. Bulletin Epid\u00e9miologique Hebdomadaire. Paris: Sant\u00e9 Publique France; 2018."},{"key":"2621_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tmaid.2017.09.002","volume":"19","author":"M Shellvarajah","year":"2017","unstructured":"Shellvarajah M, Hatz C, Schlagenhauf P. Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: a survey of European expert opinion and international recommendations. Travel Med Infect Dis. 2017;19:49\u201355.","journal-title":"Travel Med Infect Dis."},{"key":"2621_CR24","unstructured":"Groupe recommandations de la Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise. Prise en charge et pr\u00e9vention du paludisme. Mise \u00e0 jour 2017 des RPC 2007. Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise, 2017. \n                    www.infectiologie.com\/fr\/actualites\/paludisme-rcp-2017_n-html\n                    \n                  ."},{"key":"2621_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","volume":"2","author":"DG Lalloo","year":"2016","unstructured":"Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJ, Chiodini PL, PHE Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines 2016. J Infect. 2016;2:635\u201349.","journal-title":"J Infect."},{"key":"2621_CR26","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3201\/eid2006.131508","volume":"20","author":"N Hong Van","year":"2014","unstructured":"Van Hong N, Amambua-Ngwa A, Tuan NQ, Cuong do D, Giang NT, Van Dung N, et al. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2014;20:1199\u2013202.","journal-title":"Emerg Infect Dis."},{"key":"2621_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4269\/ajtmh.2000.62.82","volume":"62","author":"B Pradines","year":"2000","unstructured":"Pradines B, Spiegel A, Rogier C, Tall A, Mosnier J, Fusai T, et al. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. Am J Trop Med Hyg. 2000;62:82\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"2621_CR28","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","volume":"45","author":"B Pradines","year":"2001","unstructured":"Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, et al. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother. 2001;45:1746\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"2621_CR29","doi-asserted-by":"publisher","first-page":"e0192717","DOI":"10.1371\/journal.pone.0192717","volume":"13","author":"KE Schmidt","year":"2018","unstructured":"Schmidt KE, Kuepper JM, Schumak B, Alferink J, Hofmann A, Hawland SW, et al. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators. PLoS One. 2018;13:e0192717.","journal-title":"PLoS One"},{"key":"2621_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.reprotox.2007.07.011","volume":"24","author":"Z Kazy","year":"2007","unstructured":"Kazy Z, Puho EH, Czeizel AE. Effects of doxycycline treatment during pregnancy for birth outcomes. Reprod Toxicol. 2007;24:279\u201380.","journal-title":"Reprod Toxicol"},{"key":"2621_CR31","first-page":"315","volume":"25","author":"HW Horne","year":"1980","unstructured":"Horne HW, Kundsin RB. The role of mycoplasma among 81 consecutive pregnancies: a prospective study. Int J Fertil. 1980;25:315\u20137.","journal-title":"Int J Fertil."},{"key":"2621_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejogrb.2017.11.010","volume":"220","author":"U Kasprzykowska","year":"2017","unstructured":"Kasprzykowska U, Sobieszczanska B, Duda-Madej A, Secewicz A, Nowicka J, Gosciniak G. A twelve-year retrospective analysis of prevalence and microbial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of Lower Silesia in Poland. Eur J Obstet Gynecol Reprod Biol. 2017;220:44\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"2621_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.15698\/mic2016.09.525","volume":"3","author":"CM O\u2019Connell","year":"2016","unstructured":"O\u2019Connell CM, Ferone ME. Chlamydia trachomatis genital infections. Microb Cell. 2016;3:390\u2013403.","journal-title":"Microb Cell"},{"key":"2621_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/QCO.0b013e328360db58","volume":"26","author":"R Capoccia","year":"2013","unstructured":"Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis. 2013;26:231\u201340.","journal-title":"Curr Opin Infect Dis."},{"issue":"suppl 2","key":"2621_CR35","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1093\/cid\/cix661","volume":"65","author":"F Bianchi-Jassir","year":"2017","unstructured":"Bianchi-Jassir F, Seale AC, Kohli-Lynch M, Lawn JE, Bartiett L, Cuttland C, et al. Preterm birth associated with group B Streptococcus maternal colonization worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl 2):S133\u201342.","journal-title":"Clin Infect Dis"},{"key":"2621_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cmi.2016.10.010","volume":"23","author":"J Kikhney","year":"2017","unstructured":"Kikhney J, von Sch\u00f6ning D, Steding I, Schulze J, Petrich A, Hiergeist A, et al. Is Ureaplasma spp. the leading causative agent of acute chorioamniotis in women with preterm birth? Clin Microbiol Infect. 2017;23:119.","journal-title":"Clin Microbiol Infect."},{"key":"2621_CR37","doi-asserted-by":"publisher","first-page":"e0146531","DOI":"10.1371\/journal.pone.0146531","volume":"11","author":"E Saez-Lopez","year":"2016","unstructured":"Saez-Lopez E, Guiral E, Fernandez-Orth D, Villanueva S, Gonc\u00e9 A, Lopez M, et al. Vaginal versus obstetric infection Escherichia coli isolates among pregnant women: antimicrobial resistance and genetic virulence profile. PLoS One. 2016;11:e0146531.","journal-title":"PLoS One"},{"key":"2621_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12879-016-2103-0","volume":"17","author":"M Kobayashi","year":"2017","unstructured":"Kobayashi M, Conklin LM, Bigogo G, Jagero G, Hampton L, Fleming-Dutra KE, et al. Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged\u2009<\u20095\u00a0years prior to the introduction of 10-valent pneumococcal conjugate vaccine\u2014Kenya, 2009\u20132010. BMC Infect Dis. 2017;17:25.","journal-title":"BMC Infect Dis"},{"key":"2621_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12879-017-2713-1","volume":"17","author":"BT Tadesse","year":"2017","unstructured":"Tadesse BT, Asley EA, Ongarello S, Havumaki J, Wijegoonewardena M, Gonzalez IJ, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17:616.","journal-title":"BMC Infect Dis"},{"key":"2621_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","volume":"15","author":"R Cross","year":"2016","unstructured":"Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting\u00a0doxycycline\u00a0in pregnancy and early childhood\u2013time to rebuild its reputation? Expert Opin Drug Saf. 2016;15:367\u201382.","journal-title":"Expert Opin Drug Saf."},{"key":"2621_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/AOG.0b013e3182a5fdfd","volume":"122","author":"D Meaney-Delman","year":"2013","unstructured":"Meaney-Delman D, Rasmussen SA, Beigi RH, Zotti ME, Hutchings Y, Bower WA, et al. Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol. 2013;122:885\u2013900.","journal-title":"Obstet Gynecol"},{"key":"2621_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0301-2115(99)00112-8","volume":"88","author":"AE Czeizel","year":"2000","unstructured":"Czeizel AE, Rockenbauer M. A population-based case\u2013control teratologic study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2000;88:27\u201333.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2621_CR43","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0029-7844(97)00005-7","volume":"89","author":"AE Czeizel","year":"1997","unstructured":"Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol. 1997;89:524\u20138.","journal-title":"Obstet Gynecol"},{"key":"2621_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","volume":"23","author":"WO Cooper","year":"2009","unstructured":"Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer SM, Gideon PS, et al. Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol. 2009;23:18\u201328.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2621_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/pds.2179","volume":"21","author":"D Molgaard-Nielsen","year":"2012","unstructured":"Molgaard-Nielsen D, Hviid A. Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2012;21:246\u201353.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2621_CR46","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","volume":"163","author":"KS Crider","year":"2009","unstructured":"Crider KS, Cleves MA, Reefhuis J. Antibacterial medication use during pregnancy and risk of birth defects. Arch Pediatr Adolesc Med. 2009;163:978\u201385.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2621_CR47","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.fertnstert.2017.04.003","volume":"107","author":"L Kaye","year":"2017","unstructured":"Kaye L, Bartels C, Bartolucci A, Engmann L, Nulsen J, Benadiva C. Old habits die hard: retrospective analysis of outcomes with use of corticosteroids and antibiotics before embryo transfer. Fertil Steril. 2017;107:1336\u201340.","journal-title":"Fertil Steril"},{"key":"2621_CR48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/humrep\/13.2.409","volume":"13","author":"SE Lanzendorf","year":"1998","unstructured":"Lanzendorf SE, Nehchiri F, Mayer JF, Oehninger S, Muasher SJ. A prospective, randomized, double-blind study for the evaluation of assisted hatching in patients with advanced maternal age. Hum Reprod. 1998;13:409\u201313.","journal-title":"Hum Reprod"},{"key":"2621_CR49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","volume":"107","author":"GG Nahum","year":"2006","unstructured":"Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol. 2006;107:1120\u201338.","journal-title":"Obstet Gynecol"},{"key":"2621_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1708-8305.2009.00380.x","volume":"17","author":"U Hellgren","year":"2010","unstructured":"Hellgren U, Rombo L. Alternatives for malaria prophylaxis during the first trimester of pregnancy: our personal view. J Travel Med. 2010;17:130\u20132.","journal-title":"J Travel Med."},{"key":"2621_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00003081-200203000-00004","volume":"45","author":"GG Briggs","year":"2002","unstructured":"Briggs GG. Drug effect on the fetus and breast-fed infant. Clin Obstet Gynecol. 2002;45:6\u201321.","journal-title":"Clin Obstet Gynecol"},{"key":"2621_CR52","first-page":"115","volume":"3","author":"V Venila","year":"2014","unstructured":"Venila V, Madhu V, Rajesh R, Ealla KK, Velidandla SR, Santoshi S. Tetracycline-induced discoloration of deciduous teeth: case series. J Int Oral Health. 2014;3:115\u20139.","journal-title":"J Int Oral Health."},{"key":"2621_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0002-9378(66)90328-0","volume":"96","author":"AH Kutscher","year":"1966","unstructured":"Kutscher AH, Zegarelli EV, Tovell HM, Hochberg B, Hochberg B, Hauptman J. Discoloration of deciduous teeth induced by administration of tetracycline antepartum. Am J Obstet Gynecol. 1966;96:291\u20132.","journal-title":"Am J Obstet Gynecol"},{"key":"2621_CR54","first-page":"75","volume":"25","author":"MT Genot","year":"1970","unstructured":"Genot MT, Golan HP, Porter PJ, Kass EH. Effect of administration of tetracycline in pregnancy on the primary dentition of the offspring. J Oral Med. 1970;25:75\u20139.","journal-title":"J Oral Med."},{"key":"2621_CR55","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/154405910508400703","volume":"84","author":"CJ Tredwin","year":"2005","unstructured":"Tredwin CJ, Scully C, Bagan-Sebastian JV. Drug-induced disorders of teeth. J Dent Res. 2005;84:596\u2013602.","journal-title":"J Dent Res"},{"key":"2621_CR56","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-4632.2004.02108.x","volume":"43","author":"AR Sanchez","year":"2004","unstructured":"Sanchez AR, Rogers RS, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol. 2004;43:709\u201315.","journal-title":"Int J Dermatol"},{"key":"2621_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12936-017-1797-9","volume":"16","author":"T Gaillard","year":"2017","unstructured":"Gaillard T, Briolant S, Madamet M, Pradines B. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017;16:148.","journal-title":"Malar J."},{"key":"2621_CR58","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","volume":"166","author":"SR Todd","year":"2015","unstructured":"Todd SR, Dahlgren FS, Traeger MS, Beltr\u00e1n-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr. 2015;166:1246\u201351.","journal-title":"J Pediatr"},{"key":"2621_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0009922806290026","volume":"46","author":"B Volovitz","year":"2007","unstructured":"Volovitz B, Shkap R, Amir J, Calderon S, Varsano I, Nussinovitch M. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr. 2007;46:121\u20136.","journal-title":"Clin Pediatr"},{"key":"2621_CR60","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/00006454-199805000-00019","volume":"17","author":"ME Lochary","year":"1998","unstructured":"Lochary ME, Lockhart PB, Williams WT. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J. 1998;17:429\u201331.","journal-title":"Pediatr Infect Dis J."},{"key":"2621_CR61","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1093\/jac\/dkx245","volume":"72","author":"H P\u00f6yh\u00f6nen","year":"2017","unstructured":"P\u00f6yh\u00f6nen H, Nurmi M, Peitola V, Alaluusua S, Ruuskanen O, L\u00e4hdesm\u00e4ki T. Dental staining after doxycycline use in children. J Antimicrob Chemother. 2017;72:2887\u201390.","journal-title":"J Antimicrob Chemother"},{"key":"2621_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/jama.1964.03060290111037","volume":"188","author":"HF Dowling","year":"1964","unstructured":"Dowling HF, Lepper MH. Hepatic reactions to tetracycline. JAMA. 1964;188:307\u20139.","journal-title":"JAMA"},{"key":"2621_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJM196311072691903","volume":"269","author":"JC Schultz","year":"1963","unstructured":"Schultz JC, Adamson JS, Workman WW, Norman TD. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med. 1963;269:999\u20131004.","journal-title":"N Engl J Med"},{"key":"2621_CR64","first-page":"1386","volume":"269","author":"RC Briggs","year":"1963","unstructured":"Briggs RC. Tetracycline and liver disease. N Engl J Med. 1963;269:1386.","journal-title":"N Engl J Med"},{"key":"2621_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/17843286.1992.11718230","volume":"47","author":"F Lienart","year":"1992","unstructured":"Lienart F, Morissens M, Jacobs P, Ducobu J. Doxycycline and hepatotoxicity. Acta Clin Belg. 1992;47:205\u20138.","journal-title":"Acta Clin Belg"},{"key":"2621_CR66","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.clinthera.2009.05.012","volume":"31","author":"ME Carrascosa","year":"2009","unstructured":"Carrascosa ME, Lucena MI, Andrade RJ, Caviedes JR, Lavin AC, Mones JC, et al. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther. 2009;31:1014\u20139.","journal-title":"Clin Ther"},{"key":"2621_CR67","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/pds.1547","volume":"17","author":"SB Meropol","year":"2008","unstructured":"Meropol SB, Chan KA, Chen Z, Finelstein JA, Hennessy S, Lautenbach E, et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf. 2008;17:523\u201332.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2621_CR68","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2710.2007.00853.x","volume":"32","author":"PC Heaton","year":"2007","unstructured":"Heaton PC, Fenwick SR, Brewer DE. Association between tetracycline or doxycycline and hepatotoxicity: a population based case\u2013control study. J Clin Pharm Ther. 2007;32:483\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"2621_CR69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12936-017-1698-y","volume":"16","author":"A Silva-Pinto","year":"2017","unstructured":"Silva-Pinto A, Ruas R, Almeida F, Duro R, Silva A, Abreu C, et al. Artemether\u2013lumefantrine and liver enzyme abnormalities in non-severe Plasmodium falciparum malaria in returned travelers: a retrospective comparative study with quinine\u2013doxycycline in a Portuguese centre. Malar J. 2017;16:43.","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-018-2621-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:15:59Z","timestamp":1576282559000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-018-2621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2621"],"URL":"https:\/\/doi.org\/10.1186\/s12936-018-2621-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"469"}}